Bausch & Lomb (BLCO) Share-based Compensation (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Share-based Compensation came in at $38.0 million in Q2 2026, up 26.67% YoY from $30.0 million in Q2 2025, and up 11.76% on a QoQ basis from $34.0 million in Q1 2026.
Bausch & Lomb (BLCO) Share-based Compensation (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Share-based Compensation data on file, last reported at $38.0 million in Q2 2026.
- Quarterly Share-based Compensation rose 26.67% year-over-year to $38.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $163.0 million (up 49.54% YoY) and the FY2025 annual result came in at $149.0 million, up 61.96% from the prior year.
- Share-based Compensation improved to $38.0 million in Q2 2026, from $34.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $64.0 million in Q4 2025 to a low of $11.0 million in Q2 2022.
- A 5-year average of $24.9 million and a median of $23.0 million in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation declined 26.67% — and 2025, when it soared 137.04%.
- Tracing BLCO's Share-based Compensation over 5 years: stood at $17.0 million in 2022, then slipped by 5.88% to $16.0 million in 2023, then jumped by 68.75% to $27.0 million in 2024, then soared by 137.04% to $64.0 million in 2025, then slumped by 40.62% to $38.0 million in 2026.
- The last three Share-based Compensation figures came in at $38.0 million (Q2 2026), $34.0 million (Q1 2026), and $64.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 67.10 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 55.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 42.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 27.46 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 29.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 38.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 33.00 Mn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 38.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.00 Mn |
| Jun 30, 2026 | 38.00 Mn |
| Mar 31, 2026 | 34.00 Mn |
| Mar 31, 2026 | 34.00 Mn |
| Dec 31, 2025 | 64.00 Mn |
| Dec 31, 2025 | 64.00 Mn |
| Sep 30, 2025 | 27.00 Mn |
| Sep 30, 2025 | 27.00 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Dec 31, 2024 | 27.00 Mn |
| Dec 31, 2024 | 27.00 Mn |
| Sep 30, 2024 | 24.00 Mn |
| Sep 30, 2024 | 24.00 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Mar 31, 2024 | 19.00 Mn |
| Mar 31, 2024 | 19.00 Mn |